Oncopeptides Shares Dip 0.58% as Market Capitalisation Hits SEK 672 M – Key Biotech Update
Oncopeptides AB shares dip 0.58% amid volatile biotech market; learn how its pro‑drug platform positions the Stockholm biotech for future growth.
2 minutes to read